The Independent Value of Neutrophil to Lymphocyte Ratio in Gouty Arthritis: A Narrative Review
Yiming Chen,Jian Liu,Yang Li,Chengzhi Cong,Yuedi Hu,Xianheng Zhang,Qi Han
DOI: https://doi.org/10.2147/jir.s430831
IF: 4.5
2023-10-17
Journal of Inflammation Research
Abstract:Yiming Chen, 1, 2 Jian Liu, 1– 3 Yang Li, 1 Chengzhi Cong, 1 Yuedi Hu, 1 Xianheng Zhang, 1 Qi Han 1 1 Department of Rheumatology, the First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, People's Republic of China; 2 Anhui Key Laboratory of Application and Development of Internal medicine of Modern Chinese Medicine, Anhui University of Chinese Medicine, Hefei, Anhui Province, People's Republic of China; 3 National Traditional Chinese Medicine Inheritance and Innovation Center, Hefei, Anhui Province, People's Republic of China Correspondence: Jian Liu, Department of Rheumatology, the First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui Province, People's Republic of China, Tel +86 13955109537, Email Since the incidence of gouty arthritis (GA) exhibits yearly increases, accurate assessment and early treatment have significant values for improving disease conditions and monitoring prognosis. Neutrophil to lymphocyte ratio (NLR) is a common indicator in blood routine, which has the characteristics of easy access and low cost. In recent years, NLR has been proven to be an effective indicator for guiding the diagnosis, treatment, and prognosis of various diseases. Moreover, NLR has varying degrees of relationship with various inflammatory biomarkers, which can affect and reflect the inflammatory response in the body. This paper reviews the independent value of NLR for GA and its underlying molecular pathological mechanisms, intending to contribute to the further application of NLR. Keywords: neutrophil to lymphocyte ratio, gouty arthritis, inflammatory response, neutrophils, disease activity Gouty arthritis (GA) is one of the most common forms of inflammatory arthritis, bringing huge economic and social burdens. 1,2 According to the study data of the Global Burden of Disease, there are 41.2 million GA patients worldwide as of 2017. 3 The estimated global age-standardized incidence rate and annual incidence rate of GA are 510.6 and 91.8 per 100,000 people, respectively, which increases by 7.2% and 5.5% compared with 1990. 4,5 These changes are more pronounced in economically developed countries or regions. 6 The gold standard for GA diagnosis is the presence of birefringent urate crystal in synovial fluid under a polarization microscope. 1 However, patients show low acceptance due to the invasive nature of this procedure. Currently, the examination methods for GA include X-ray, ultrasound, computed tomography, magnetic resonance imaging, etc. However, these imaging techniques are complex, restrictive, and expensive. 7,8 The indicators reflecting the inflammatory activity of GA include C-reactive protein, erythrocyte sedimentation rate and IL-1β, etc. 9 However, the sensitivity and specificity of these indicators are not excellent. 10 There are many comorbidities in patients with GA, which are the main causes of death in patients with GA. 11 At present, the method to accurately predict the risk and prognosis of GA comorbidities has not been found. Therefore, it is urgent to find a simpler, cheaper, and less restrictive assessment method for GA while ensuring its effectiveness. During the GA process, there exists a persistent immune inflammatory response mediated by inflammatory biomarkers such as immune cells, inflammatory mediators, and chemokines. 12 Emerging evidence has indicated that biomarkers can be used as characteristic indicators to evaluate the activity and prognosis of GA, facilitating the optimization of treatment plans. 9,13–15 Neutrophil to lymphocyte ratio (NLR) is a composite biomarker obtained by dividing the neutrophil count by the lymphocyte count in blood routine, which is the most common test in clinical practice. 16,17 In recent years, NLR has been found to predict the activity and prognosis of rheumatic diseases (including GA). 17–21 This review summarizes existing evidence on the relationship between NLR and GA, evaluates whether NLR can guide clinical measures, explores the potential pathophysiological mechanisms of NLR, and thereby provides a foundation for future research. NLR is a parameter in blood routine testing, which is easy to obtain, cost-effective, rapid to test, and integrates two different but complementary immune pathways. As a composite biomarker, NLR is more capable of reflecting systemic inflammation than individual biomarkers, and its potential role in clinical practice is supported by its ability to predict the occurrence and development of various diseases. 22,23 The NLR value of healthy adults ranges from 0.78 to 3.53, with an average of 1.65. 24</ -Abstract Truncated-
immunology